Transgenic Expression of Proximal Tubule Peroxisome Proliferator-activated Receptor-alpha in Mice Confers Protection During Acute Kidney Injury
Overview
Authors
Affiliations
Our previous studies suggest that peroxisome proliferator-activated receptor-alpha (PPARalpha) plays a critical role in regulating fatty acid beta-oxidation in kidney tissue and this directly correlated with preservation of kidney morphology and function during acute kidney injury. To further study this, we generated transgenic mice expressing PPARalpha in the proximal tubule under the control of the promoter of KAP2 (kidney androgen-regulated protein 2). Segment-specific upregulation of PPARalpha expression by testosterone treatment of female transgenic mice improved kidney function during cisplatin or ischemia-reperfusion-induced acute kidney injury. Ischemia-reperfusion injury or treatment with cisplatin in wild-type mice caused inhibition of fatty-acid oxidation, reduction of mitochondrial genes of oxidative phosphorylation, mitochondrial DNA, fatty-acid metabolism, and the tricarboxylic acid cycle. Similar injury in testosterone-treated transgenic mice resulted in amelioration of these effects. Similarly, there were increases in the levels of 4-hydroxy-2-hexenal-derived lipid peroxidation products in wild-type mice, which were also reduced in the transgenic mice. Similarly, necrosis of the S3 segment was reduced in the two injury models in transgenic mice compared to wild type. Our results suggest proximal tubule PPARalpha activity serves as a metabolic sensor. Its increased expression without the use of an exogenous PPARalpha ligand in the transgenic mice is sufficient to protect kidney function and morphology, and to prevent abnormalities in lipid metabolism associated with acute kidney injury.
How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease.
Masenga S, Desta S, Hatcher M, Kirabo A, Lee D Curr Res Physiol. 2024; 8:100133.
PMID: 39665027 PMC: 11629568. DOI: 10.1016/j.crphys.2024.100133.
Metabolic Chaos in Kidney Disease: Unraveling Energy Dysregulation.
Gupta P, Zhu S, Gui Y, Zhou D J Clin Med. 2024; 13(22).
PMID: 39597916 PMC: 11594442. DOI: 10.3390/jcm13226772.
Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases.
Chow B, Yu Lee I, Liu C, Liu Y Exp Biol Med (Maywood). 2024; 249:10142.
PMID: 38993197 PMC: 11238193. DOI: 10.3389/ebm.2024.10142.
Neferine alleviates acute kidney injury by regulating the PPAR-α/NF-κB pathway.
Xiong Y, Zhong J, Chen W, Li X, Liu H, Li Y Clin Exp Nephrol. 2024; 28(10):969-987.
PMID: 38658442 DOI: 10.1007/s10157-024-02504-8.
The key role of altered tubule cell lipid metabolism in kidney disease development.
Lee L, Doke T, Mukhi D, Susztak K Kidney Int. 2024; 106(1):24-34.
PMID: 38614389 PMC: 11193624. DOI: 10.1016/j.kint.2024.02.025.